Unknown

Dataset Information

0

Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus.


ABSTRACT: Aspergillus infection is a well-known complication of severe influenza and severe acute respiratory syndrome coronavirus (SARS-CoV), and these infections have been related with significant morbidity and mortality even when appropriately diagnosed and treated. Recent studies have indicated that SARS-CoV-2 might increase the risk of invasive pulmonary aspergillosis (IPA). Here, we report the first case of Aspergillus ochraceus in a SARS-CoV-2 positive immunocompetent patient, which is complicated by pulmonary and brain infections. Proven IPA is supported by the positive Galactomannan test, culture-positive, and histopathological evidence. The patient did not respond to voriconazole, and liposomal amphotericin B was added to his anti-fungal regimen. Further studies are needed to evaluate the prevalence of IPA in immunocompetent patients infected with SARS-CoV-2. Consequently, testing for the incidence of Aspergillus species in lower respiratory secretions and Galactomannan test of COVID-19 patients with appropriate therapy and targeted anti-fungal therapy based on the primary clinical suspicion of IPA are highly recommended.

SUBMITTER: Hakamifard A 

PROVIDER: S-EPMC7901383 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3854705 | biostudies-literature
| S-EPMC8474008 | biostudies-literature
| S-EPMC2546708 | biostudies-literature
| S-EPMC9833957 | biostudies-literature
| S-EPMC7344504 | biostudies-literature
| S-EPMC7360421 | biostudies-literature
| S-EPMC8014135 | biostudies-literature
| S-EPMC3122724 | biostudies-literature
| S-EPMC7491399 | biostudies-literature
| S-EPMC9109117 | biostudies-literature